Comparative Pharmacology
Head-to-head clinical analysis: CHLORHEXIDINE GLUCONATE versus HEXASCRUB.
Peer-Reviewed Evidence
Head-to-head clinical analysis: CHLORHEXIDINE GLUCONATE versus HEXASCRUB.
CHLORHEXIDINE GLUCONATE vs HEXASCRUB
Comparing the clinical profiles, pharmacokinetic behaviors, and safety indices of these two therapeutic agents.
Cationic bisbiguanide that disrupts microbial cell membranes by binding to negatively charged cell wall components, increasing permeability and causing leakage of cytoplasmic contents; also inhibits bacterial enzymes and precipitates cytoplasmic constituents.
Antiseptic agent that disrupts microbial cell membranes via surfactant activity, reducing surface tension and denaturing proteins.
Oral rinse: 15 mL of 0.12% solution swished in mouth for 30 seconds twice daily; topical: apply 2% cream or lotion to affected area 2-3 times daily.
1-2 sprays applied topically to wound once daily.
None Documented
None Documented
Terminal half-life approximately 12-24 hours; may be prolonged in hepatic impairment.
Terminal elimination half-life: 22-30 hours; clinical context: steady-state achieved after 4-5 days of daily dosing.
Primarily renal (10-30% unchanged) and biliary/fecal (majority as metabolites).
Renal excretion of unchanged drug: 60-70%; fecal elimination: 20-30%; biliary excretion: <5%.
Category C
Category C
Antiseptic
Antiseptic